-+ 0.00%
-+ 0.00%
-+ 0.00%

NXERA Pharma announced that vamorolone has been selected as a pilot program to accelerate reimbursement for rare disease treatment in South Korea.

智通财经·11/06/2026 08:49:13
语音播报
NXERA Pharma announced that vamorolone has been selected as a pilot program to accelerate reimbursement for rare disease treatment in South Korea.